Neuromyelitis Optica: all 178 studies
Page 1 of 2. Open to participants first (78), then studies with results posted, then the rest; newest registration first within each.
- Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients HealthNot yet recruitingNCT07902479Not applicable
- Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum DisorderNot yet recruitingNCT07809724Phase 2
- A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune DiseaseNot yet recruitingNCT07804004Phase 1/2
- A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSDRecruitingNCT07762872
- Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum DisorderRecruitingNCT07738952Phase 1/2
- Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic ToolNot yet recruitingNCT07704294
- Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory TrialNot yet recruitingNCT07699770Phase 4
- Study on Efficacy Evaluation of Ripertamab in the Treatment of Neuromyelitis Optica Spectrum DisordersNot yet recruitingNCT07685678Phase 1/2
- A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyNot yet recruitingNCT07676266Phase 1
- Cohort Study on Neuroimmune Diseases in the Reproductive AgeRecruitingNCT07653984
- The Italian Multiple Sclerosis and Related Disorders RegisterEnrolling by invitationNCT07636876
- Evaluate the Safety and Tolerability of CE211NS21 in Patients With AQP4-IgG-positive NMOSD RelapseNot yet recruitingNCT07595965Phase 1
- The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.Not yet recruitingNCT07592754Early Phase 1
- Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)RecruitingNCT07557420Phase 3
- Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.RecruitingNCT07526493Phase 1
- Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable PatientsNot yet recruitingNCT07526298
- Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum DisorderRecruitingNCT07420296Phase 3
- Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World StudyRecruitingNCT07410039Phase 4
- Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune DiseasesNot yet recruitingNCT07392528Early Phase 1
- Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)RecruitingNCT07377305Not applicable
- A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard TherapyNot yet recruitingNCT07341828Phase 1
- Tongji NADs CohortNot yet recruitingNCT07333196
- Multiple Sclerosis Versus Neuromyelitis Optica Spectrum DisorderNot yet recruitingNCT07304960
- Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy AgingRecruitingNCT07202494
- Inectolizumab With Steroid Optimization in Newly Treated NMOSDNot yet recruitingNCT07159893Not applicable
- Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSDNot yet recruitingNCT07132398Phase 3
- Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune DiseasesRecruitingNCT07085676Phase 1
- Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune DiseasesRecruitingNCT07022197Phase 1/2
- Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With AutoantibodiesRecruitingNCT06941584
- Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune DiseasesRecruitingNCT06939166Early Phase 1
- Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSDRecruitingNCT06885957
- Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.RecruitingNCT06865274Not applicable
- HANDLE-a Real World Study on Satralizumab in NMOSDRecruitingNCT06829524
- Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSDRecruitingNCT06780709Not applicable
- Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum DisorderRecruitingNCT06763848Not applicable
- A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)RecruitingNCT06697535Phase 2
- A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersRecruitingNCT06680037Phase 1
- Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)Enrolling by invitationNCT06643858
- The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum DisordersRecruitingNCT06620809Phase 1
- Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum DisorderNot yet recruitingNCT06561009Phase 1/2
- A Study to Evaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) PatientsNot yet recruitingNCT06557174Phase 1/2
- Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating DiseasesRecruitingNCT06541626
- Biomarkers in Autoimmune Disease of Nervous SystemRecruitingNCT06502015
- FcRn Antagonists (Efgartigimod) for Acute NMOSD AttackNot yet recruitingNCT06497374Phase 2
- Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.Not yet recruitingNCT06485232Early Phase 1
- Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)RecruitingNCT06474520Not applicable
- Efgartigimod for the Treatment of Acute Optic NeuritisRecruitingNCT06453694Phase 2
- National, Multicentric Registry Study on Neuroimmunological Diseases in ChinaRecruitingNCT06443333
- A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)RecruitingNCT06413654Phase 2/3
- Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum DisorderRecruitingNCT06398158
- Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum DisorderEnrolling by invitationNCT06374264Not applicable
- Study of Ultomiris® (Ravulizumab) Safety in PregnancyRecruitingNCT06312644
- Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.RecruitingNCT06280755
- A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyRecruitingNCT06249438Phase 1
- A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum DisordersNot yet recruitingNCT06212245Phase 4
- Efgartigimod in Acute Neuromyelitis Optica Spectrum DisordersNot yet recruitingNCT06118398
- Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum DisordersNot yet recruitingNCT06068829
- Longitudinal Cortical Demyelination in Multiple Sclerosis and Related DisordersRecruitingNCT05982925
- Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor TherapiesRecruitingNCT05966467
- Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During PregnancyRecruitingNCT05909761
- Inebilizumab in Acute Neuromyelitis Optica Spectrum DisordersRecruitingNCT05891379
- Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSDRecruitingNCT05566769Not applicable
- Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum DisorderRecruitingNCT05549258Phase 2
- Ofatumumab in AQP4-IgG Seropositive NMOSDRecruitingNCT05504694Phase 1/2
- Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM)Not yet recruitingNCT05415579
- Azathioprine in MOGADRecruitingNCT05349006Phase 3
- MS-ResearchBiomarkerSRecruitingNCT05204459
- A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)RecruitingNCT05199688Phase 3
- China National Registry of Neuro-Inflammatory DiseasesRecruitingNCT05154370
- Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)RecruitingNCT05145361Early Phase 1
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)RecruitingNCT05017142
- Biorepository and Registry for Plasma Exchange PatientsRecruitingNCT05004493
- CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)Enrolling by invitationNCT04886492
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemRecruitingNCT04561557Early Phase 1
- Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)RecruitingNCT04106830
- French Registry for Monitoring Pregnancies for Multiple SclerosisRecruitingNCT03900221
- Optic Neuritis Differential Diagnosis StudyRecruitingNCT03370965Not applicable
- Stem Cell Ophthalmology Treatment Study IIRecruitingNCT03011541Not applicable
- A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An InterventionTerminatedNCT05269667Phase 4Results posted
- A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)CompletedNCT04660539Phase 3Results posted
- High Frequency Impulse Therapy for Neuropathic Pain in NMOSDCompletedNCT04614454Phase 2Results posted
- An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSDCompletedNCT04201262Phase 3Results posted
- A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum DisorderTerminatedNCT04155424Phase 2/3Results posted
- Scrambler Trial for Pain in NMOSDCompletedNCT03452176Not applicableResults posted
- Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD PatientsCompletedNCT03002038Phase 2/3Results posted
- Neuromyelitis Optica (NMO) & CetirizineCompletedNCT02865018Phase 1/2Results posted
- Ublituximab for Acute Neuromyelitis Optica (NMO) RelapsesCompletedNCT02276963Phase 1Results posted
- N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum DisordersCompletedNCT02200770Phase 2/3Results posted
- Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)CompletedNCT02166346Phase 2Results posted
- Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)CompletedNCT02073279Phase 3Results posted
- Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)CompletedNCT02028884Phase 3Results posted
- An Open Label Extension Trial of Eculizumab in Relapsing NMO PatientsCompletedNCT02003144Phase 3Results posted
- A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)TerminatedNCT01892345Phase 3Results posted
- Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO ExacerbationsCompletedNCT01777412Phase 1Results posted
- C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica ExacerbationCompletedNCT01759602Phase 1Results posted
- An Open Label Study of the Effects of Eculizumab in Neuromyelitis OpticaCompletedNCT00904826Phase 1/2Results posted
- Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple SclerosisCompletedNCT00879658Phase 2Results posted
- Hematopoietic Stem Cell Transplant in Devic's DiseaseCompletedNCT00787722Phase 1/2Results posted
- Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in RussiaTerminatedNCT07247292
- Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum DisorderActive, not recruitingNCT07184840Phase 2